| Literature DB >> 21633623 |
Abstract
OBJECTIVE: A common disorder requiring symptom palliation in palliative and end-of-life care is cancer. Cancer pain is recognized as a global health burden. This paper sought to systematically examine the extent to which there is an adequate scientific research base on cancer pain and its reporting characteristics in the palliative care journal literature.Entities:
Keywords: Cancer pain; Palliative care research; Reporting characteristics
Year: 2011 PMID: 21633623 PMCID: PMC3098545 DOI: 10.4103/0973-1075.78451
Source DB: PubMed Journal: Indian J Palliat Care ISSN: 0973-1075
Figure 1Schematic flowchart for data synthesis used in this study
Overall journals’ characteristics
| Total number of journals, N | 19 |
| MEDLINE-indexed/ CINAHL-indexed | 12/7 |
| Multidisciplinary/ Medical/ Nursing/ Other | 15/2/1/1 |
| General/ Cancer-specific | 17/2 |
| Supportive/ Palliative/Hospice/ End-of-Life | 2/ 15/ 1/ 1 |
Figure 2Overall prevalence of reporting cancer pain (corrected reporting rate) in all the palliative care journals
Comparison of articles published in palliative care journals and their respective reporting rates of articles on cancer pain
| Total number of articles (2009-2010) | Articles in English with abstracts N2 | Number of articles on cancer AND pain IN abstract N1 | Gross percentage reporting N1/N2 % Gross reporting rate (GRR) | Number of articles ‘mainly’ on cancer pain N3 | Corrected percentage of reporting N3/N2% Corrected reporting rate (CRR) | |
|---|---|---|---|---|---|---|
| Am J Hosp Palliat Care | 180 | 137 | 15 | 10.94 | 10 | 7.29 |
| BMC Palliat Care | 42 | 42 | 3 | 7.14 | 1 | 2.38 |
| Curr Opin Support Palliat Care | 99 | 86 | 6 | 6.97 | 4 | 4.65 |
| End Life Care J | 91 | 39 | 2 | 5.12 | 1 | 2.56 |
| Eur J Palliat Care | 149 | 87 | 12 | 13.79 | 7 | 8.04 |
| Hosp Manage Adv | 289 | 0 | 0 | NA | NA | NA |
| Indian J Palliat Care | 70 | 38 | 8 | 21.05 | 5 | 13.15 |
| Int J Palliat Nurs | 178 | 131 | 4 | 3.05 | 2 | 1.52 |
| Internet J Pain Symptom Control Palliat Care | 16 | 13 | 0 | 0 | NA | NA |
| J Pain Palliat Care Pharmacother | 113 | 84 | 7 | 8.33 | 5 | 5.95 |
| J Palliat Care | 77 | 38 | 7 | 18.42 | 6 | 15.78 |
| J Palliat Med | 470 | 246 | 22 | 8.94 | 13 | 5.28 |
| J Soc Work End Life Palliat Care | 17 | 12 | 0 | 0 | NA | NA |
| J Support Oncol | 87 | 42 | 6 | 14.28 | 4 | 9.52 |
| Palliat Care Res Treat | 6 | 0 | 0 | NA | NA | NA |
| Palliat Med | 199 | 161 | 16 | 9.93 | 8 | 4.96 |
| Palliat Support Care | 118 | 101 | 3 | 2.97 | 0 | 0 |
| Progress Palliat Care | 70 | 0 | 0 | NA | NA | NA |
| Support Care Cancer | 329 | 312 | 40 | 12.82 | 26 | 8.33 |
| Total number of articles, N or % | 2600 | 1569 | 151 | 9.62 | 92 | 5.86 |
- Medline-indexed journals;
- Cinahl-indexed journals;
- medical;
- nursing;
- other (social work);
- multidisciplinary;
- general;
- cancer-specific;
NA - Not assessable since there were no available articles as per required criteria
Figure 3Comparison of reporting rates of articles ‘mainly’ on cancer pain-corrected reporting rate between palliative care journals
Figure 4Comparison of corrected reporting rates between MEDLINE- and CINAHL-indexed journals
Figure 5Comparison of corrected reporting rates between multidisciplinary, medical and nursing palliative care journals
Figure 6Comparison of corrected reporting rates between general and cancer-specific palliative care journals
Characteristics of articles on cancer pain in terms of their type of article, method of research and study design
| Total number of articles on cancer pain N4 | Type of articles | Number of articles N5 (%= N5/N4) | Types of research methods | Number of articles N6 (%= N6/N4) | Study designs | Number of articles N7 (%= N7/N4) |
|---|---|---|---|---|---|---|
| 92 | Original articles | 68 (73.91) | Qualitative studies | 12 (13.04) | Randomized clinical trial | 0 |
| Non-randomized clinical trial | 2 (2.17) | |||||
| Cohort study | 1 (1.08) | |||||
| Case control study | 0 | |||||
| Cross-sectional study | 9 (9.78) | |||||
| Case report | 0 | |||||
| Quantitative studies | 56 (60.86) | Randomized clinical trial | 8 (8.69) | |||
| Non-randomized clinical trial | 12 (13.04) | |||||
| Cohort study | 11 (11.95) | |||||
| Case control study | 0 | |||||
| Cross-sectional study | 10 (10.86) | |||||
| Case report | 15 (16.30) | |||||
| Review articles | 24 (26.09) | Narrative reviews | 18 (19.56) | |||
| Systematic reviews | 6 (6.52) |
Figures in parenthesis are in percentage